| Followers | 436 |
| Posts | 41282 |
| Boards Moderated | 0 |
| Alias Born | 10/07/2010 |
Sunday, September 01, 2019 12:16:50 PM
you need to wait for the name and ticker change first. than the share structure change.
and as for as promotions - they can say they are not paid but it they frontload and put out those promos - I guess they are paid?
Microcapdaily/Pennystocks.com(Adam Heimann)/ EquityBulletin.com
then add in "community" websites, facebook and twitter sites - I think You have plenty of promo activity here.
Any idea how Justin plans to pay for any of these acquisitions or whatever the heck he plans on putting in this shell? You actually think he will put it in for FREE? and allow all the longs all that free money? think about that a moment. has there ever been a reverse merger that doesn't eventually screw over all the LONGS? Plenty of $$ can be made in the short term on the hype alone - but the people that walk away with that money are holding onto the naïve shareholders money that were told nonsense like FLOAT LOCKDOWN and going to $500/share.
heavy caution advised! Lock in those profits and don't be left holding the bag!!!
and as for as promotions - they can say they are not paid but it they frontload and put out those promos - I guess they are paid?
Microcapdaily/Pennystocks.com(Adam Heimann)/ EquityBulletin.com
then add in "community" websites, facebook and twitter sites - I think You have plenty of promo activity here.
Any idea how Justin plans to pay for any of these acquisitions or whatever the heck he plans on putting in this shell? You actually think he will put it in for FREE? and allow all the longs all that free money? think about that a moment. has there ever been a reverse merger that doesn't eventually screw over all the LONGS? Plenty of $$ can be made in the short term on the hype alone - but the people that walk away with that money are holding onto the naïve shareholders money that were told nonsense like FLOAT LOCKDOWN and going to $500/share.
heavy caution advised! Lock in those profits and don't be left holding the bag!!!
Recent MAJI News
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
- Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes • ACCESS Newswire • 09/29/2025 04:35:00 PM
- Exousia Pro Reports Positive Outcome in Legal Proceeding • ACCESS Newswire • 09/26/2025 02:30:00 PM
